Azenta
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 27 in the most recent period (2026/Q3).
- Total institutional ownership rose 8.0 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 123.35% +7.95pp
- Institutions
- 329 +27
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Politan Capital Management, L.P. | -- | 11.07% |
| Martin Madaus | Interim President, CEO & Director | 0.10% |
| Robyn Davis | Independent Vice Chair of the Board | 0.10% |
| John P. Marotta | Former Chief Executive Officer | 0.09% |
| Lawrence Lin | Chief Financial Officer | 0.06% |
| Erica McLaughlin | Independent Director | 0.05% |
| Frank Casal | Independent Chairperson | 0.05% |
| William Cornog | Independent Director | 0.05% |
| Alan Malus | Former Independent Director | 0.04% |
| Tina Nova | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-21 | Martin Madaus | Interim President, CEO & Director | Sale to Issuer | -1,294 | $36.01 |
| 2026-09-21 | Martin Madaus | Interim President, CEO & Director | Sale to Issuer | -1,456 | $34.28 |
| 2026-09-14 | Erik Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer | Other Acquisition | +4,586 | -- |
| 2026-09-13 | Martin Madaus | Interim President, CEO & Director | Other Acquisition | +36,653 | -- |
| 2026-09-13 | Ephraim Starr | Senior Vice President | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Olga Pirogova | Senior VP & Chief HR Officer | Other Acquisition | +15,272 | -- |
| 2026-09-13 | William Martin | Senior Vice President & President of Multiomics | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Lawrence Lin | Chief Financial Officer | Other Acquisition | +30,544 | -- |
| 2026-08-08 | Olga Pirogova | Senior VP & Chief HR Officer | Sale to Issuer | -1,085 | $32.04 |
| 2026-07-30 | Ephraim Starr | Senior Vice President | Private Acquisition | +335 | $24.17 |
| 2026-05-17 | William Cornog | Independent Director | Open Market Acquisition | +10,000 | $16.38 |
| 2026-05-14 | Ephraim Starr | Senior Vice President | Sale to Issuer | -3,621 | $16.02 |
| 2026-04-27 | William Martin | Senior Vice President & President of Multiomics | Other Acquisition | +17,790 | $24.24 |
| 2026-02-05 | Tina Nova | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Martin Madaus | Interim President, CEO & Director | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Robyn Davis | Independent Vice Chair of the Board | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Erica McLaughlin | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Dipal Doshi | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Frank Casal | Independent Chairperson | Other Acquisition | +7,243 | $27.85 |
| 2026-02-04 | Quentin Koffey | Independent Director | Other Acquisition | +5,663 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Azenta discussion 0 comments